Table 3 Mean (SEM) percentage changes from baseline in Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in the total group and in the Relapsing Remitting (RR) and Progressive (P) subgroups
1 month | 3 months | 6 months | |||||||
|---|---|---|---|---|---|---|---|---|---|
Total | RR | SP/PP | Total | RR | SP/PP | Total | RR | SP/PP | |
MSSES-Function | 4.5% (4.1) | 0.9% (10.0) | 15.1% (47.2) | −0.2% (5.2) | 6.2% (21.9) | 5.3% (51.1) | 1.4% (4.8) | 1.2% (12.9) | 1.5% (40.7) |
MSSES-Control | 10.0% (6.1) | 3.8% (30.0) | 15.1% (47.2) | 8.0% (8.4) | −0.2% (33.9)% | 15.5% (68.3) | 23.4% (9.5) | 24.8%* (37.2) | 22.1% (75.2) |
IPA-Limitations | −4.1% (2.4) | −3.8% (18.6) | −4.6% (14.1) | −3.3% (2.6) | −6.3% (13.6)% | −0.7% (18.8) | −3.1% (2.8) | −5.3% (19.3) | −1.1% (15.9) |
IPA-Problems | −3.4% (2.5) | −6.0% (17.0) | −1.7% (15.2) | −6.5% (2.9) | −8.4%* (18.35) | −4.9% (17.4) | −2.2% (3.3) | −3.9% (22.5) | −0.8% (18.1) |